Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-031597

President & CEO sold 12,791 shares at $83.39 ($1,066,641)

From the SEC's structured data for this filing

Trades in this filing

ROBIN HOWARD W · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-05-16 Sale : show line 1 in the form −12,791 $83.39 $1,066,641 224,356 D
Open-market sales · 12,791 sh · avg $83.39 · $1,066,641
Loading xslF345X03/doc4.xml…